Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07814586) titled 'Prognostic Evaluation and Systematic Re-Assessment of Cholangiocarcinoma Therapy' on Sept. 2.
Study Type: Observational
Primary Sponsor: Karolinska University Hospital
Condition:
Intrahepatic Cholangiocarcinoma
Perihilar Cholangiocarcinoma
Recruitment Status: Not recruiting
Date of First Enrollment: September 2026
Target Sample Size: 900
To know more, visit https://clinicaltrials.gov/study/NCT07814586
Disclaimer: Curated by HT Syndication....